107 related articles for article (PubMed ID: 6280044)
1. Giant axonal neuropathy: an inborn error of organization of intermediate filaments.
Pena SD
Muscle Nerve; 1982 Feb; 5(2):166-72. PubMed ID: 6280044
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical studies of intermediate filament aggregates and their relationship to microtubules in cultured skin fibroblasts from patients with giant axonal neuropathy.
Pena SD; Opas M; Turksen K; Kalnins VI; Carpenter S
Eur J Cell Biol; 1983 Sep; 31(2):227-34. PubMed ID: 6315439
[TBL] [Abstract][Full Text] [Related]
3. Aggregation of a subpopulation of vimentin filaments in cultured human skin fibroblasts derived from patients with giant axonal neuropathy.
Bousquet O; Basseville M; Vila-Porcile E; Billette de Villemeur T; Hauw JJ; Landrieu P; Portier MM
Cell Motil Cytoskeleton; 1996; 33(2):115-29. PubMed ID: 8635201
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the intermediate filament apparatus in skin fibroblasts from patients with giant axonal neuropathy: effect of trypsin.
Manetti R; Ceccarini C; Guazzi G; Federico A; Tiezzi A; Bugnoli M; Ceccarini EC
Cell Motil Cytoskeleton; 1987; 8(1):55-60. PubMed ID: 3308126
[TBL] [Abstract][Full Text] [Related]
5. Infantile neuroaxonal dystrophy and giant axonal neuropathy: are they related?
Begeer JH; Houthoff HJ; van Weerden TW; de Groot CJ; Blaauw EH; le Coultre R
Ann Neurol; 1979 Dec; 6(6):540-8. PubMed ID: 575280
[TBL] [Abstract][Full Text] [Related]
6. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy.
Bomont P; Cavalier L; Blondeau F; Ben Hamida C; Belal S; Tazir M; Demir E; Topaloglu H; Korinthenberg R; Tüysüz B; Landrieu P; Hentati F; Koenig M
Nat Genet; 2000 Nov; 26(3):370-4. PubMed ID: 11062483
[TBL] [Abstract][Full Text] [Related]
7. Giant axonal neuropathy: intermediate filament aggregates in cultured skin fibroblasts.
Pena SD
Neurology; 1981 Nov; 31(11):1470-3. PubMed ID: 6273766
[TBL] [Abstract][Full Text] [Related]
8. Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins.
Lazarides E
Annu Rev Biochem; 1982; 51():219-50. PubMed ID: 6180679
[No Abstract] [Full Text] [Related]
9. Calcium/calmodulin induces phosphorylation of vimentin and myosin light chain and cell rounding in cultured adrenal cells.
Almahbobi G; Korn M; Hall PF
Eur J Cell Biol; 1994 Apr; 63(2):307-15. PubMed ID: 8082655
[TBL] [Abstract][Full Text] [Related]
10. A case of giant axonal neuropathy showing focal aggregation and hypophosphorylation of intermediate filaments.
Mohri I; Taniike M; Yoshikawa H; Higashiyama M; Itami S; Okada S
Brain Dev; 1998 Dec; 20(8):594-7. PubMed ID: 9865543
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of magnetic resonance imaging findings in a family with giant axonal neuropathy confirmed by genetic studies.
Ravishankar S; Goel G; Rautenstrauss CP; Nalini A
Neurol India; 2009; 57(2):181-4. PubMed ID: 19439850
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype analysis in patients with giant axonal neuropathy (GAN).
Koop O; Schirmacher A; Nelis E; Timmerman V; De Jonghe P; Ringelstein B; Rasic VM; Evrard P; Gärtner J; Claeys KG; Appenzeller S; Rautenstrauss B; Hühne K; Ramos-Arroyo MA; Wörle H; Moilanen JS; Hammans S; Kuhlenbäumer G
Neuromuscul Disord; 2007 Aug; 17(8):624-30. PubMed ID: 17587580
[TBL] [Abstract][Full Text] [Related]
13. Childhood giant axonal neuropathy. Case report and review of the literature.
Tandan R; Little BW; Emery ES; Good PS; Pendlebury WW; Bradley WG
J Neurol Sci; 1987 Dec; 82(1-3):205-28. PubMed ID: 2831308
[TBL] [Abstract][Full Text] [Related]
14. Clinical, pathological and molecular findings in two siblings with giant axonal neuropathy (GAN): report from India.
Nalini A; Gayathri N; Yasha TC; Ravishankar S; Urtizberea A; Huehne K; Rautenstrauss B
Eur J Med Genet; 2008; 51(5):426-35. PubMed ID: 18595793
[TBL] [Abstract][Full Text] [Related]
15. Alterations in lipid metabolism gene expression and abnormal lipid accumulation in fibroblast explants from giant axonal neuropathy patients.
Leung CL; Pang Y; Shu C; Goryunov D; Liem RK
BMC Genet; 2007 Mar; 8():6. PubMed ID: 17331252
[TBL] [Abstract][Full Text] [Related]
16. [Giant axonal neuropathy: intermediate filament disease with involvement of the peripheral and central nervous system].
Buissonnière RF; Routon MC; Robain O; Ponsot G; Arthuis M
Rev Neurol (Paris); 1989; 145(5):355-61. PubMed ID: 2662338
[TBL] [Abstract][Full Text] [Related]
17. Vimentin, the 57 000 molecular weight protein of fibroblast filaments, is the major cytoskeletal component in immature glia.
Dahl D; Rueger DC; Bignami A; Weber K; Osborn M
Eur J Cell Biol; 1981 Jun; 24(2):191-6. PubMed ID: 7285936
[TBL] [Abstract][Full Text] [Related]
18. Giant axonal neuropathy: observations on a further patient.
Donaghy M; Brett EM; Ormerod IE; King RH; Thomas PK
J Neurol Neurosurg Psychiatry; 1988 Jul; 51(7):991-4. PubMed ID: 2849642
[TBL] [Abstract][Full Text] [Related]
19. Restoration of cytoskeleton homeostasis after gigaxonin gene transfer for giant axonal neuropathy.
Mussche S; Devreese B; Nagabhushan Kalburgi S; Bachaboina L; Fox JC; Shih HJ; Van Coster R; Samulski RJ; Gray SJ
Hum Gene Ther; 2013 Feb; 24(2):209-19. PubMed ID: 23316953
[TBL] [Abstract][Full Text] [Related]
20. Senescence and cytoskeleton: overproduction of vimentin induces senescent-like morphology in human fibroblasts.
Nishio K; Inoue A; Qiao S; Kondo H; Mimura A
Histochem Cell Biol; 2001 Oct; 116(4):321-7. PubMed ID: 11702190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
